Table 2.
Primary and secondary outcomes of surgical site infection prevalence rates.
Control surveillance |
Intervention surveillance |
Adjusted estimatesc |
|||||||
---|---|---|---|---|---|---|---|---|---|
SSIsa | Procedures | Unadjusted PRb | SSIsa | Procedures | Unadjusted PRb | PRR (95% CI) | p value | ||
All SSIs | 1171 | 148,365 | 0.79 | 781 | 89,339 | 0.87 | 1.10 (0.94–1.30) | 0.25 | |
Complex SSIsd | 739 | 148,365 | 0.50 | 472 | 89,339 | 0.53 | 1.09 (0.89–1.34) | 0.40 | |
Superficial SSIs | 432 | 148,365 | 0.29 | 309 | 89,339 | 0.35 | 1.26 (1.00–1.58) | 0.070 |
PR = prevalence rate. PRR = prevalence rate ratio. SSI = surgical site infection.
214 SSIs that met present at time of surgery criteria were excluded, including 102 SSIs on the control arm (PR 0•07) and 112 SSIs on the intervention arm (PR 0.13).
Prevalence rates are given per 100 procedures performed.
Models included effects for time period and intervention phase, and models were adjusted for hospital, median wound class, median American Society of Anesthesiology score, and operation time score.
Complex SSIs included deep-incisional and organ/space SSIs.